Boujediane O, Erdozain AM, Ortega JE. Benefit/risk assessment of SARS-CoV-2 vaccines approved in the European Union. Osag [Internet]. 2021 Dec. 31 [cited 2026 Nov. 12];5(2). Available from: https://aldizkariak.ueu.eus/index.php/osagaiz/article/view/409